Top news of the week: 03.03.2020.
#BioTech #IoT #cybersecurity #thenewcambridge #FlyEaglesFly #ArtificialIntelligence #health #DL #FutureofWork #HealthTech
Healthcare
US plans trial of Gilead coronavirus drug remdesivir
The U.S. is planning a clinical trial of Gilead's experimental drug for the novel coronavirus, according to a posting on a government clinical trials database.
Another High-Profile Spark Therapeutics Executive Departs As Merger with Roche Continues https://t.co/FtJ8uaLVyR https://t.co/Mrs7x1KnXX
OpenAnother High-Profile Spark Therapeutics Executive Departs As Merger with Roche Continues
After four years with the gene therapy company, Chief Medical Officer Kathleen Reape will resign her position.
RT @meggophone: I fact-checked some of the misinformation from the admin about coronavirus, which experts say is causing confusion and could be dangerous https://t.co/BhAeYrjCBv
OpenTrump’s no stranger to misinformation. But with the coronavirus, experts say that’s dangerous
President Trump’s no stranger to misinformation. But with the coronavirus, experts say that’s not just confusing, it's dangerous.
Biotech health care innovations meet security challenges #BioTech #cybersecurity #health via https://t.co/2sI0UxJbpn https://t.co/qs6Meha4ln
OpenBiotech health care innovations meet security challenges
The level and speed of innovations taking place in the biotech industry are baffling. On the one hand, it makes us hopeful we can quickly reduce the number of illnesses and their ...
It's all of @ChrisPascale6's favorite things! Philly *and* biotech.
#thenewcambridge #FlyEaglesFly
https://t.co/LwAQF7znzE
OpenThis isn’t a ‘biotech bubble,’ it’s ‘Philadelphia’s moment’ to become a center for gene therapy, says Penn-based CEO
Philadelphia is where the future economy around gene therapy is coming together, establishing the area as an international nexus for new treatments. "Philadelphia is not going to lose this ...
Takeda swoops in to buy little biotech partner and its celiac drug poised to 'change standard of care' #BioTech via https://t.co/2sI0UxJbpn https://t.co/welh2dGvs3
OpenTakeda swoops in to buy little biotech partner and its celiac drug poised to 'change standard of care'
Having spent three years carefully grooming PvP Biologics and its drug for celiac disease, Takeda is happy enough with the proof-of-concept data to buy it all. “Build to buy” was always the ...
RT @HaroldSinnott: #ArtificialIntelligence yields new antibiotic
👉🏻 https://t.co/seccz562Bz
@MIT @techreview
#HealthTech #healthcare #AI #ML #DL #IoT #FutureofWork
cc @_atanas_ @IrmaRaste @evankirstel @jblefevre60 @HealthcareLdr @DigitalMedDoc
@DigitalColmer @digitalcloudgal
OpenArtificial intelligence yields new antibiotic
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
Cambridge biotech Moderna leads in the race for a coronavirus vaccine #BioTech via https://t.co/2sI0UxJbpn https://t.co/As9p5cGx7j
OpenCambridge biotech Moderna leads in the race for a coronavirus vaccine
The company has already produced an experimental medicine, but its CEO cautions that an approved treatment is more than a year away.